Latest Content

Dental Care May Cause Financial Burdens in Head and Neck Cancer

October 7th 2024, 1:00pm

By Ashley Chan

Article

In some patients with head and neck cancer, those who require dental care after cancer treatment may face financial burdens because of out-of-pocket costs.

Taking a Drink From the Fire Hose

October 6th 2024, 3:00pm

By Mary Brooks

Article

Several colleagues, patients and caregivers nominated Jill May, B.S.N., RN, OCN, for the 2024 Extraordinary Healer Award for her dedicating to caring for those with gastrointestinal cancers.

FDA Receives Application to Review D-VRd in Multiple Myeloma Subset

October 5th 2024, 6:00pm

By Darlene Dobkowski, MA

Article

The biologics license application seeks potential approval of a Darzalex Faspro-based regimen for newly diagnosed multiple myeloma ineligible for transplant.

Non-Surgical Options May Maintain Relapse-Free Survival in Rectal Cancer Subset

October 5th 2024, 2:00pm

By Ariana Pelosci

Article

Distance relapse-free survival was maintained in patients with pMMR locally advanced rectal cancer through non-operative management of the disease.

Opdivo with Abraxane May Expand Therapeutic Opportunities For MIBC

October 4th 2024, 9:00pm

By Spencer Feldman

Article

Patients with muscle-invasive bladder cancer experienced safe medical and surgical treatment with the NURE-combo.

Telehealth Palliative Care Comparable to In-Person Visits

October 4th 2024, 7:00pm

By Alex Biese

Article

Research has shown that among patients with advanced non-small cell lung cancer, early palliative care delivered by video is as effective as in-person care.

4 Years After My Bone Marrow Transplant for AML

October 4th 2024, 5:00pm

By Mary Sansone

Article

As a survivor of acute myeloid leukemia, some things are no longer going to be normal, but who wants to be normal?

Mike Peters of the Alarm in Remission, Broadway Star Gavin Creel Dies and More

October 4th 2024, 3:00pm

By Alex Biese

Article

From good news for a rock star to the deaths of stage and screen stars, here’s what’s happening in the cancer space this week.

It’s October and Yes, We’re Aware

October 4th 2024, 1:00pm

By Ann Bancroft

Article

Just like how Christmas decorations creep into November before Thanksgiving, I hope Pinktober does not creep into September.

My Brain Cancer Journey After Giving Birth

October 3rd 2024, 9:00pm

By Caitie Doyle

Article

Two months after giving birth to my daughter, I noticed something was unusual, which led to my diagnosis of anaplastic oligodendroglioma.

Education on MPN Symptoms, Treatments Leads to Greater Involvement in Care

October 3rd 2024, 7:00pm

By Darlene Dobkowski, MA

Article

An expert explained the importance of education and involvement in care for patients with myeloproliferative neoplasms.

Understanding Multiple Myeloma Symptoms

October 3rd 2024, 5:00pm

By Ronald Chin

Article

Reflecting on the pain I experienced before my diagnosis of multiple myeloma, I realized how important it was to pay attention to the related symptoms.

FDA Approves Presurgical, Postsurgical Opdivo for NSCLC

October 3rd 2024, 3:42pm

By Alex Biese

Article

The Food and Drug Administration has approved Opdivo before and after surgery for some with non-small cell lung cancer.

FDA Grants Priority Review to Enhertu for HER2-Low and -Ultralow Breast Cancer

October 3rd 2024, 3:00pm

By Darlene Dobkowski, MA

Article

The antibody-drug conjugate will be reviewed for the potential treatment of previously treated, unresectable or metastatic HER2-low or -ultralow breast cancer.

Perioperative Opdivo Extends Event-Free Survival in Lung Cancer

October 3rd 2024, 1:00pm

By Kyle Doherty

Article

Receiving perioperative Opdivo for non-small cell lung cancer showed event-free survival benefits compared with placebo.